 |
|
(eh-fuh-lih-ZOO-mab)
| | A monoclonal antibody used to treat psoriasis (a chronic skin disease). It is also being studied in the treatment of graft-versus-host disease (GVHD) of the skin after a donor stem cell transplant. Efalizumab binds to a molecule called LFA-1, and blocks the action of T cells (a type of white blood cell). It is a type of immunosuppressant. Also called Raptiva. |
| Previous Definitions: | edema, edotecarin, edrecolomab, EEG, EF5 | | Next Definitions: | efaproxiral, effector cell, efficacy, effusion, eflornithine |
|
|
